LAZARD ASSET MANAGEMENT LLC - ANTARES PHARMA INC ownership

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$84,000
+42.4%
20,567
+22.9%
0.00%
Q4 2021$59,000
+126.9%
16,736
+133.9%
0.00%
Q3 2021$26,000
-58.1%
7,156
-52.9%
0.00%
Q1 2021$62,000
+12.7%
15,178
+9.1%
0.00%
Q4 2020$55,0000.0%13,913
-32.3%
0.00%
Q3 2020$55,000
-8.3%
20,562
-6.4%
0.00%
Q2 2020$60,000
+46.3%
21,959
+23.7%
0.00%
Q1 2020$41,000
-6.8%
17,746
+86.6%
0.00%
Q4 2019$44,000
+238.5%
9,511
+127.9%
0.00%
Q3 2019$13,0004,1740.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders